Table 3.

Distribution of the allele frequencies of EZH2 genotypes in controls and oral cancer patients

Variable	Controls (N=1104) n (%)	Patients (N=1152) n (%)	OR (95% CI)	p value
rs6950683
T	748 (67.8%)	837 (72.7%)	1.00
C	356 (32.2%)	315 (27.3%)	0.791 (0.660-0.948)	P=0.011*
rs2302427
C	863 (78.2%)	912 (79.2%)	1.00
G	241 (21.8%)	240 (20.8%)	0.942 (0.770-1.153)	P=0.564
rs3757441
T	765 (69.3%)	845 (73.4%)	1.00
C	339 (30.7%)	307 (26.6%)	0.820 (0.683-0.984)	P=0.033*
rs41277434
A	1068 (96.7%)	1115 (96.8%)	1.00
C	36 (3.3%)	37 (3.2%)	0.984 (0.617-1.570)	P=0.948

The odds ratios (ORs) and with their 95% confidence intervals (CIs) were estimated by logistic regression models.

^*Statistically significant at P < 0.05.